Justin Leushner has had an extensive and diverse business career in the life sciences and biotechnology industries. He has participated in many entrepreneurial start-up companies, which have included medical devices, diagnostics, and therapeutics. He was also responsible for developing a national molecular diagnostics program for MDS Inc., Canada’s largest life science’s company, and served as a business analyst and portfolio advisor to the Canadian Medical Discoveries Fund. In 2004, Justin co-founded Sernova Corp. currently traded on the Toronto Stock Exchange. In addition he developed an Islet Transplant Program for the London Health Sciences Centre and served as a Director for Health Care Restructuring. Justin is active in the development and commercialization of medical technologies. An MBA graduate of Western University’s Ivey School of Business, Justin also holds a B.Sc. in Cell Physiology/Genetics from the University of British Columbia and numerous technical designations in Forensic Science and Molecular Biology.